eRF1 (ETF1) Human shRNA Plasmid Kit (Locus ID 2107)

CAT#: TR313159

ETF1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided



Need custom shRNA service?
Get a free quote

CNY 6790.00


货期*
2周

规格
    • 1 kit

Product images

推荐一起购买 (2)
TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4090.00


ETF1 (eRF1) mouse monoclonal antibody, clone OTI2E3 (formerly 2E3)
    • 100 ul

CNY 1999.00
CNY 2700.00

Specifications

Product Data
Product Name eRF1 (ETF1) Human shRNA Plasmid Kit (Locus ID 2107)
Locus ID 2107
UniProt ID P62495
Synonyms D5S1995; ERF; ERF1; RF1; SUP45L1; TB3-1
Vector pRS
Format Retroviral plasmids
Kit Components ETF1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 2107). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free.
RefSeq NM_001256302, NM_001282185, NM_001291974, NM_001291975, NM_004730, NR_045992, NR_045994, NM_004730.1, NM_004730.2, NM_004730.3, NM_001256302.1, NM_001291974.1, NM_001291975.1, NM_001282185.1, BC014269, BC088358, BM819293, NM_001364160, NR_157090, NM_001291975.2, NM_004730.4, NM_001256302.2
Summary This gene encodes a class-1 polypeptide chain release factor. The encoded protein plays an essential role in directing termination of mRNA translation from the termination codons UAA, UAG and UGA. This protein is a component of the SURF complex which promotes degradation of prematurely terminated mRNAs via the mechanism of nonsense-mediated mRNA decay (NMD). Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 6, 7, and X. [provided by RefSeq, Aug 2013]
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.

For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...